A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Clinical trial NCT05365581 · RECRUITING
Trial details
- NCT number
- NCT05365581
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2028-05-31
- Enrollment
- 398
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.